Symbiotic formulation in experimentally induced liver fibrosis in rats: Intestinal microbiota as a key point to treat liver damage?

Liver International

Volumn 33, Issue 5, 2013, Pages 687-697

  D'Argenio, Giuseppe ^a,b,c   Cariello, Rita ^c,d   Tuccillo, Concetta ^c,d   Mazzone, Giovanna ^a   Federico, Alessandro ^c,d   Funaro, Annalisa ^d   De Magistris, Laura ^c,d   Grossi, Enzo ^e   Callegari, Maria L ^f   Chirico, Marilena ^d   Caporaso, Nicola ^a,c   Romano, Marco ^c,d   Morelli, Lorenzo ^f   Loguercio, Carmela ^c,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^c Centro Interuniversitario Ricerche su Alimenti Nutrizione e Apparato Digerente (CIRANAD)   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e Bracco SpA   (Italy)

^f UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

Intestinal microbiota; Rat liver fibrosis; Symbiotic treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COLLAGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLORTEC; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; MESSENGER RNA; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLOSTRIDIUM; CLOSTRIDIUM BARTLETTII; CLOSTRIDIUM IRREGULARIS; CONTROLLED STUDY; DOWN REGULATION; FECES ANALYSIS; GENE SEQUENCE; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; LACTOBACILLUS INTESTINALIS; LACTOBACILLUS PARACASEI; LACTOBACILLUS REUTERI; LACTOBACILLUS VAGINALIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; LONG TERM CARE; MALE; NONHUMAN; PEDIOCOCCUS; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; CARBON TETRACHLORIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOKINES; DENATURING GRADIENT GEL ELECTROPHORESIS; FECES; GALACTANS; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GLUTAMINE; LACTOBACILLUS; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PERMEABILITY; PROBIOTICS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876074684     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12117     Document Type: Article

References (33)

1. El Bialy SA, Abd El Kader KF, El-Ashmawy MB. Current progress in antifibrotics. Curr Med Chem 2011; 18: 3082-92. Review.
2. Cesaro C, Tiso A, Del Prete A, et al. Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis 2011; 43: 431-8.
3. Guerrero Hernández I, Torre Delgadillo A, Vargas Vorackova F, et al. Intestinal flora, probiotics, and cirrhosis. Ann Hepatol 2008; 7: 120-4.
4. Almeida J, Galhenage S, Yu J, Kurtovic J, et al. Gut flora and bacterial translocation in chronic liver disease. World J Gastroeneterol 2006; 12: 1493-502.
5. Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Gastrointest Liver Physiol 2010; 298: G807-19.
6. Loguercio C, De Simone T, Federico A, et al. Gut-liver axis: a new point of attack to treat chronic liver damage? Am J Gastreoenterol 2002; 97: 2144-6.
7. Loguercio C, Federico A, Tuccillo C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 2005; 39: 540-3.
8. Riordan SM, Williams R. Gut flora and hepatic encephalopathy in patients with cirrhosis. N Engl J Med 2010; 362: 1140-2.
9. Morelli L, Garbagna N, Rizzello F, et al. In vivo association to human colon of Lactobacillus paracasei B21060: map from biopsies. Digest Liver Dis 2006; 38: 894-8.
10. Federico A, Tuccillo C, Grossi E, et al. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study. Eur Rev Med Pharmacol Sci 2009; 13: 285-93.
11. Dastych M, Dastych M Jr, Novotnà H, et al. Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease. Dig Dis Sci 2008; 53: 2789-92.
12. Akama F, Nishino R, Makino S, et al. The effect of probiotics on gastric mucosal permeability in humans administered with aspirin. Scand J Gastroenterol 2011; 46: 831-6.
13. Cariello R, Federico A, Sapone A, et al. Intestinal permeability in patients with chronic liver diseases: its relationship with the aetiology and the entity of liver damage. Dig Liver Dis 2010; 42: 200-4.
14. Generoso M, De Rosa M, De Rosa R. Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability. J Chromatogr B 2003; 783: 349-57.
15. Liu H, Zhang S, Yu A, et al. Studies on intestinal permeability of cirrhotic patients by analysis lactulose and mannitol in urine with HPLC/RID/MS. Bioorg Med Chem Lett 2004; 14: 2339-44.
16. Miller AM, Horiguchi N, Jeong WI, et al. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res 2011; 35: 787-93.
17. Walter J, Tannock GW, Tilsala-Timisjarvi A, et al. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol 2000; 66: 297-303.
18. Furet JP, Quénée P, Tailliez P. Molecular quantification of lactic acid bacteria in fermented milk products using real-time quantitative PCR. Int J Food Microbiol 2004; 97: 197-207.
19. Velayudham A, Dolganiuc A, Ellis M, et al. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 2009; 49: 989-97.
20. Malagon I, Onkenhout W, Klok M, et al. Rhamnose and rhamnitol in dual sugar permeability tests. J Pediatr Gastroenterol Nutr 2006; 43: 265-6.
21. -induced cirrhosis. Arq Gastroenterol 2010; 47: 188-92.
22. Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2008; 49: 1877-87.
23. Yan AW, Fouts DE, Brandl J, et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011; 53: 96-105.
24. Mutlu E, Keshavarzian A, Engen P, et al. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res 2009; 33: 1836-46.
25. Natarajan SK, Ramamoorthy P, Thomas S, et al. Intestinal mucosal alterations in rats with carbon tetrachloride-induced cirrhosis: changes in glycosylation and luminal bacteria. Hepatology 2006; 43: 837-46.
26. Plummer JL, Ossowicz CJ, Whibley C, et al. Influence of intestinal flora on the development of fibrosis and cirrhosis in a rat model. J Gastroenterol Hepatol 2000; 15: 1307-11.
27. Chiva M, Soriano G, Rochat I, et al. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol 2002; 37: 456-62.
28. Lee WK, Fujisawa T, Kawamura S, et al. Isolation and identification of clostridia from the intestine of laboratory animals. Lab Anim 1991; 25: 9-15.
29. 4-induced fibrosis. PLoS ONE 2011; 6: e23037.
30. Jalanka-Tuovinen J, Salonen A, Nikkilä J, et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS ONE 2011; 6: e23035.
31. Nardone G, Compare D, Liguori E, et al. Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury. Am J Physiol Gastrointest Liver Physiol 2010; 299: G669-76.
32. Leithner K, Grabovac V, Albrecht K, et al. Permeation studies on freshly excised rat gastric mucosa: influence of pH. Drug Dev Ind Pharm 2011; 37: 518-25.
33. De Foneska A. Kaunitz JD Gastroduodenal mucosal defense. Curr Opin Gastroenterol 2010; 26: 604-10.